{"id":17984,"date":"2011-12-14T00:00:00","date_gmt":"2011-12-14T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/resource\/designer-drugs-the-new-frontier\/"},"modified":"2023-10-06T19:27:14","modified_gmt":"2023-10-06T19:27:14","slug":"designer-drugs-new-frontier","status":"publish","type":"resource","link":"https:\/\/www.cadca.org\/pt\/resource\/designer-drugs-new-frontier\/","title":{"rendered":"Drogas de design: a nova fronteira"},"content":{"rendered":"<p>H\u00e1 uma nova classe de drogas em constante mudan\u00e7a e seus efeitos s\u00e3o diferentes de tudo que j\u00e1 vimos. O uso de drogas sint\u00e9ticas, como sais de banho e especiarias, est\u00e1 crescendo rapidamente, mesmo com a entrada em vigor de leis e decretos para ajudar a controlar sua propaga\u00e7\u00e3o.<\/p>\n<p>Durante este programa de uma hora, <em><strong>Drogas de design: a nova fronteira<\/strong><\/em>, vamos dar uma olhada nessa nova e emergente amea\u00e7a das drogas, ouvir quem est\u00e1 em maior risco e saber o que podemos fazer a respeito. Viajaremos para Bangor, Maine, onde alguns especialistas dizem que esta \u00e9 a pior epidemia de drogas que j\u00e1 viram. o show vai ao ar <strong>26 de janeiro de 2012 \u00e0s 13h EST.<\/strong><\/p>\n<p><strong>Conceitos chave:<\/strong><\/p>\n<ul>\n<li>O que s\u00e3o essas drogas projetadas?<\/li>\n<li>O que pode acontecer com as pessoas que os tomam?<\/li>\n<li>Que estrat\u00e9gias as coaliz\u00f5es podem usar para impedir seu uso?<\/li>\n<li>O que a pol\u00edcia deve saber ao abordar algu\u00e9m que possa estar usando drogas sint\u00e9ticas?<\/li>\n<\/ul>\n<p><strong>Hospedado por:<\/strong><\/p>\n<p><strong>Mary Elizabeth Elliot,<\/strong> <em>Vice-presidente de Comunica\u00e7\u00f5es, Associa\u00e7\u00e3o e Tecnologia da Informa\u00e7\u00e3o, CADCA<\/em><\/p>\n<p><strong>Provedores de conte\u00fado:<\/strong><\/p>\n<p><strong>Gary Boggs<\/strong>, <em>Agente Especial, Assistente Executivo, Office of Diversion Control, US Drug Enforcement Administration<\/em><\/p>\n<p>Gary Boggs come\u00e7ou sua carreira policial no Orange County Sheriff&#039;s Department em Orlando, Fl\u00f3rida, em 1977, onde foi designado para a Patrol Division e para a Street Drug Unit.<\/p>\n<p>Em 1985, ele se tornou um agente especial da Administra\u00e7\u00e3o Antidrogas dos Estados Unidos e foi transferido para o Escrit\u00f3rio da Divis\u00e3o de Campo de Detroit. Em 2003, ele foi transferido para o quartel-general da DEA, onde foi designado para o Escrit\u00f3rio de Intelig\u00eancia Especial como Chefe de Unidade de programas classificados.<\/p>\n<p>Em 2006, Boggs foi promovido ao cargo atual de Assistente Executivo do Vice-Administrador Assistente do Escrit\u00f3rio de Controle de Desvios. Como Assistente Executivo, ele coordena as opera\u00e7\u00f5es di\u00e1rias do Programa de Controle de Desvios; desenvolve propostas de pol\u00edtica e or\u00e7amento; fornece instru\u00e7\u00f5es aos membros do Congresso; e conduz a liga\u00e7\u00e3o com a ind\u00fastria.<\/p>\n<p>O Agente Especial Boggs \u00e9 bacharel em Ci\u00eancias em Justi\u00e7a Criminal pela Georgia Southern University.<\/p>\n<p><strong>Aaron Byzak<\/strong>, <em>Presidente, North Coastal Prevention Coalition (NCPC), Vista, Calif\u00f3rnia<\/em><\/p>\n<p>Aaron Byzak atua como presidente da North Coastal Prevention Coalition (NCPC) desde 2008 e faz parte de seu conselho desde 2003. Em 2010, o NCPC foi reconhecido pela Associa\u00e7\u00e3o Nacional de Diretores Estaduais de Abuso de \u00c1lcool e Drogas (NASADAD) com o pr\u00eamio 2010 Pr\u00eamio Nacional de Exemplar para Programas, Pr\u00e1ticas e Pol\u00edticas Inovadoras de Preven\u00e7\u00e3o do Abuso de Subst\u00e2ncias.<\/p>\n<p>Byzak \u00e9 o Diretor de Assuntos Governamentais e Comunit\u00e1rios da UC San Diego Health Sciences. Nessa fun\u00e7\u00e3o, Aaron lida com todas as atividades legislativas e de rela\u00e7\u00f5es com a comunidade em nome do Sistema de Sa\u00fade da UC San Diego, da Escola de Medicina da UCSD e da Escola de Farm\u00e1cia e Ci\u00eancias Farmac\u00eauticas Skaggs da UCSD.<\/p>\n<p>Byzak \u00e9 bacharel em Ci\u00eancias Sociais pela Chapman University e MBA em Gest\u00e3o e Pol\u00edtica de Sa\u00fade pela Paul Merage School of Business da University of California Irvine. Ele est\u00e1 atualmente matriculado no programa de certifica\u00e7\u00e3o da Cornell University em Lideran\u00e7a Executiva.<\/p>\n<p><strong>Mark Ryan<\/strong><em>, Pharm.D., Diretor, Louisiana Poison Center<\/em><\/p>\n<p>O Dr. Mark Ryan \u00e9 o Diretor do Louisiana Poison Center, onde auxilia no tratamento m\u00e9dico de pacientes envenenados ou com overdose e fornece preven\u00e7\u00e3o de envenenamento e educa\u00e7\u00e3o de conscientiza\u00e7\u00e3o para ajudar a reduzir a incid\u00eancia de envenenamentos acidentais.<\/p>\n<p>Residente vital\u00edcio da Louisiana, o Dr. Ryan formou-se na Northeast Louisiana University com um diploma de bacharel em avia\u00e7\u00e3o. \u201cAdoro pilotar avi\u00f5es, mas ajudar os outros \u00e9 minha paix\u00e3o\u201d. O Dr. Ryan completou sua gradua\u00e7\u00e3o em Farm\u00e1cia pela University of Louisiana em Monroe e recebeu seu t\u00edtulo de Doutor em Farm\u00e1cia pela University of Kansas.<\/p>\n<p>Ele \u00e9 professor assistente de medicina de emerg\u00eancia cl\u00ednica no Centro de Ci\u00eancias da Sa\u00fade da LSU em Shreveport, o que lhe d\u00e1 a oportunidade de ensinar toxicologia cl\u00ednica a estudantes de medicina, residentes, bolsistas e outros profissionais de sa\u00fade.<br \/>\nSuas \u00e1reas de interesse incluem picadas de aranha e cobra, drogas de abuso, toxicidade de acetaminofeno, resposta a emerg\u00eancias, opera\u00e7\u00f5es de farm\u00e1cia em abrigos de evacuados e agentes de oportunidade.<\/p>","protected":false},"excerpt":{"rendered":"<p>There\u2019s a new and ever-changing class of drugs out there and their effects are unlike anything we have ever seen.<\/p>","protected":false},"author":23,"featured_media":4018,"template":"","resource_type":[350],"drug_specific_issues":[],"action_to_do":[],"class_list":["post-17984","resource","type-resource","status-publish","has-post-thumbnail","hentry","resource_type-video"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Designer Drugs: The New Frontier | CADCA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/pt\/resource\/designer-drugs-new-frontier\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Designer Drugs: The New Frontier | CADCA\" \/>\n<meta property=\"og:description\" content=\"There\u2019s a new and ever-changing class of drugs out there and their effects are unlike anything we have ever seen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/pt\/resource\/designer-drugs-new-frontier\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-06T19:27:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/designerdrugs.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"258\" \/>\n\t<meta property=\"og:image:height\" content=\"172\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/designer-drugs-new-frontier\\\/\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/designer-drugs-new-frontier\\\/\",\"name\":\"Designer Drugs: The New Frontier | CADCA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/designer-drugs-new-frontier\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/designer-drugs-new-frontier\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/designerdrugs.jpg\",\"datePublished\":\"2011-12-14T00:00:00+00:00\",\"dateModified\":\"2023-10-06T19:27:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/designer-drugs-new-frontier\\\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cadca.org\\\/resource\\\/designer-drugs-new-frontier\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/designer-drugs-new-frontier\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/designerdrugs.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cadca.org\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/designerdrugs.jpg\",\"width\":258,\"height\":172},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/designer-drugs-new-frontier\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cadca.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Designer Drugs: The New Frontier\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cadca.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Designer Drugs: The New Frontier | CADCA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/pt\/resource\/designer-drugs-new-frontier\/","og_locale":"pt_PT","og_type":"article","og_title":"Designer Drugs: The New Frontier | CADCA","og_description":"There\u2019s a new and ever-changing class of drugs out there and their effects are unlike anything we have ever seen.","og_url":"https:\/\/www.cadca.org\/pt\/resource\/designer-drugs-new-frontier\/","og_site_name":"CADCA","article_modified_time":"2023-10-06T19:27:14+00:00","og_image":[{"width":258,"height":172,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/designerdrugs.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/resource\/designer-drugs-new-frontier\/","url":"https:\/\/www.cadca.org\/resource\/designer-drugs-new-frontier\/","name":"Designer Drugs: The New Frontier | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cadca.org\/resource\/designer-drugs-new-frontier\/#primaryimage"},"image":{"@id":"https:\/\/www.cadca.org\/resource\/designer-drugs-new-frontier\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/designerdrugs.jpg","datePublished":"2011-12-14T00:00:00+00:00","dateModified":"2023-10-06T19:27:14+00:00","breadcrumb":{"@id":"https:\/\/www.cadca.org\/resource\/designer-drugs-new-frontier\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/resource\/designer-drugs-new-frontier\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.cadca.org\/resource\/designer-drugs-new-frontier\/#primaryimage","url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/designerdrugs.jpg","contentUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/designerdrugs.jpg","width":258,"height":172},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/resource\/designer-drugs-new-frontier\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"Designer Drugs: The New Frontier"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/resource\/17984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/users\/23"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/resource\/17984\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/media\/4018"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/media?parent=17984"}],"wp:term":[{"taxonomy":"resource_type","embeddable":true,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/resource_type?post=17984"},{"taxonomy":"drug_specific_issues","embeddable":true,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/drug_specific_issues?post=17984"},{"taxonomy":"action_to_do","embeddable":true,"href":"https:\/\/www.cadca.org\/pt\/wp-json\/wp\/v2\/action_to_do?post=17984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}